E
Ellen Gorman
Researcher at Queen's University Belfast
Publications - 13
Citations - 447
Ellen Gorman is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 6, co-authored 7 publications receiving 85 citations.
Papers
More filters
Journal ArticleDOI
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
Gavin D. Perkins,Chen Ji,Bronwen Connolly,Keith Couper,Ranjit Lall,J Kenneth Baillie,Judy Bradley,Paul Dark,Chirag Dave,Anthony De Soyza,Anna V Dennis,Anne Devrell,Sara Fairbairn,Hakim Ghani,Ellen Gorman,Christopher A Green,Nicholas Hart,Siew Wan Hee,Zoe Kimbley,Shyam Madathil,Nicola McGowan,B Messer,Jay Naisbitt,C. Norman,Dhruv Parekh,Emma M Parkin,Jaimin Patel,Scott Regan,Clare Ross,Anthony J. Rostron,Mohammad Saim,Anita K. Simonds,Emma Skilton,Nigel Stallard,Michael C Steiner,Rama Vancheeswaran,Joyce Yeung,Daniel F. McAuley +37 more
TL;DR: In this article , the authors compared continuous positive airway pressure (CPAP) and high-flow nasal oxygen (HFNO) for acute hypoxemic respiratory failure in patients with COVID-19, and concluded that CPAP significantly reduced the risk of tracheal intubation or mortality compared with conventional oxygen therapy.
Journal ArticleDOI
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.
Alimuddin Zumla,Fu-Sheng Wang,Giuseppe Ippolito,Nicola Petrosillo,Chiara Agrati,Esam I. Azhar,Chao Chang,Sherif A. El-Kafrawy,Mohamed Osman,Laurence Zitvogel,Peter R. Galle,Franco Locatelli,Ellen Gorman,Carlos Cordon-Cardo,Cecilia O'Kane,Daniel F. McAuley,Markus Maeurer +16 more
TL;DR: MSCs should also be trialed for treatment of severe cases of MERS where mortality rates are upto 34% and MERS-CoV remains a WHO priority Blueprint pathogen.
Journal ArticleDOI
Non-invasive respiratory support strategies in COVID-19.
Ellen Gorman,Bronwen Connolly,Keith Couper,Gavin D. Perkins,Daniel F. McAuley,Daniel F. McAuley +5 more
TL;DR: In this article, non-invasive respiratory support strategies, such as continuous positive airway pressure (CPAP) or high-flow nasal oxygen (HFNO), are attractive treatment options that might avoid the need for invasive mechanical ventilation.
Posted ContentDOI
An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Gavin D. Perkins,Gavin D. Perkins,Chen Ji,Bronwen Connolly,Keith Couper,Keith Couper,Ranjit Lall,J Kenneth Baillie,Judy Bradley,Paul Dark,Paul Dark,Chirag Dave,Anthony De Soyza,Anthony De Soyza,Anna V Dennis,Anne Devrell,Sara Fairbairn,Hakim Ghani,Ellen Gorman,Christopher A Green,Nicholas Hart,Nicholas Hart,Siew Wan Hee,Zoe Kimbley,Shyam Madathil,Nicola McGowan,Benjamin Messer,Jay Naisbitt,Chloe Norman,Dhruv Parekh,Dhruv Parekh,Emma M Parkin,Jaimin Patel,Jaimin Patel,Scott Regan,Clare Ross,Anthony J. Rostron,Mohammad Saim,Anita K Simonds,Emma Skilton,Nigel Stallard,Michael C Steiner,Rama Vancheeswaran,Joyce Yeung,Joyce Yeung,Daniel F. McAuley,Daniel F. McAuley +46 more
TL;DR: In this article, the authors compared continuous positive airway pressure (CPAP) and high-flow nasal oxygenation (HFNO) for acute respiratory failure in COVID-19 patients.
Journal ArticleDOI
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
TL;DR: In this article, Mesenchymal stromal (MSC) therapies are emerging as a promising therapeutic intervention in patients with acute respiratory distress syndrome (ARDS) and sepsis due to their reparative and immunomodulatory properties.